Why the study?
New European guidelines were developed to provide updated recommendations for diagnosing, evaluating, and treating hypertension in adults across Europe.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“These clinical guidelines are one of the most important in Europe because high blood pressure affects so many people, over 25% of the adult population. The focus of the guideline is to improve the treatment of high blood pressure and blood pressure control in treated patients, which at present is not as good as it should be.”
“The 2018 ESC/ESH guidelines issue new recommendations on how to optimally treat hypertension. Drug therapy extends to additional groups of patients. Also, blood pressure values to aim at with treatment are lower than in the past. In addition, combination therapy is now recognised as the most effective initial treatment strategy in most patients.”
“We were not pleased with this because obviously I think there should be only one guideline in Europe, but there was nothing we could do. We have a lot of important experts in hypertension and thought that we could have shared guidelines and not just have a marginal position in the guidelines of the European Society of Cardiology. Also, in hypertension, cardiology is a very important component, but there are other components outside cardiology that are important for hypertension.”
The 2018 ESC/ESH guidelines provide updated recommendations for the diagnosis, risk evaluation, and treatment of hypertension in adults.
A first look at the new European Guidelines for the treatment of high blood pressure (BP) was presented at the European Society of Hypertension meeting in Barcelona on 9 June 2018. These long-awaited guidelines have been jointly developed by clinicians representing the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). The guidelines provide recommendations for doctors across Europe to diagnose hypertension, evaluate risk, when and how to treat hypertension and reduce risk, with both lifestyle advice and medications. The development of the guidelines was led by Prof. Bryan Williams (ESC Chairperson), London UK and Prof. Giuseppe Mancia (ESH Chairperson), Milan, Italy, as lead authors. ... Conflict of interest: none declared.
No takes yet. Share an insight, caveat, or question.
Williams et al. (2018) conducted a review in Hypertension. 2018 ESC/ESH HTN Guidelines was evaluated. The 2018 ESC/ESH Guidelines provide updated recommendations for the diagnosis, risk evaluation, and treatment of hypertension in adults across Europe.
Synapse has enriched 5 related papers. Consider them for comparative context: